Disease Site
Genitourinary Disease
You have full text access to this OnlineOpen article
Nonsteroidal anti-inflammatory drugs : Effects on mortality after colorectal cancer diagnosis (pages 5662–5671)Jason A. Zell, Argyrios Ziogas, Leslie Bernstein, Christina A. Clarke, Dennis Deapen, Joan A. Largent, Susan L. Neuhausen, Daniel O. Stram, Giske Ursin and Hoda Anton-Culver
Article first published online: 13 OCT 2009 | DOI: 10.1002/cncr.24705
The association between nonsteroidal anti-inflammatory drug (NSAID) use and mortality after a colorectal cancer (CRC) diagnosis was investigated among women in the California Teachers Study cohort. A total of 621 CRC cases were identified for analysis. Among CRC cases, prediagnosis regular NSAID use and prediagnosis prolonged NSAID duration independently predicted decreased CRC-specific mortality after adjustment for relevant clinical factors.
You have full text access to this OnlineOpen article
Risk of dying from prostate cancer in men randomized to screening : Differences between attendees and nonattendees (pages 5672–5679)Anna Grenabo Bergdahl, Gunnar Aus, Hans Lilja and Jonas Hugosson
Article first published online: 7 OCT 2009 | DOI: 10.1002/cncr.24680
Although the true benefits and disadvantages of prostate cancer screening are still not known, the analysis of fatal cases is important for contributing to the knowledge of the effects of prostate cancer screening on mortality. The Swedish branch of the European Randomized Study of Screening for Prostate Cancer found that nonattendees in prostate cancer screening constitute a high-risk group for death from both prostate cancer and other unrelated causes.
You have full text access to this OnlineOpen article
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma : A population-based perspective (pages 5680–5687)Giovanni Lughezzani, Umberto Capitanio, Claudio Jeldres, Hendrik Isbarn, Shahrokh F. Shariat, Philippe Arjane, Hugues Widmer, Paul Perrotte, Francesco Montorsi and Pierre I. Karakiewicz
Article first published online: 12 OCT 2009 | DOI: 10.1002/cncr.24682
Lymph node stage is an important predictor of survival in patients with metastatic renal cell carcinoma (MRCC) who are treated with cytoreductive nephrectomy. Therefore, it should be included in future prognostic models designed for MRCC patients.
Gynecologic Oncology
You have full text access to this OnlineOpen article
Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth (pages 5688–5699)Manoj Garg, Deepika Kanojia, Sushma Suri and Anil Suri
Article first published online: 7 OCT 2009 | DOI: 10.1002/cncr.24658
Earlier work revealed a significant association of SPAG9 expression in the early spread of cervical cancer, making it an attractive therapeutic target. A small interfering RNA approach was used to specifically knock down the expression of SPAG9. Findings demonstrated that knockdown of SPAG9 expression by small interfering RNA significantly suppressed cellular motility and tumor growth of cervical squamous cell carcinoma in vivo. Small interfering RNA-mediated down-regulation of SPAG9 represents a promising therapeutic approach for the treatment of cervical cancer.
Head and Neck Disease
You have full text access to this OnlineOpen article
Lymph node density is a significant predictor of outcome in patients with oral cancer (pages 5700–5710)Ziv Gil, Diane L. Carlson, Jay O. Boyle, Dennis H. Kraus, Jatin P. Shah, Ashok R. Shaha, Bhuvanesh Singh, Richard J. Wong and Snehal G. Patel
Article first published online: 18 AUG 2009 | DOI: 10.1002/cncr.24631
In the current study, the authors evaluated the utility of lymph node density (LND) as an alternative method for predicting survival. Multivariate analysis revealed that LND is superior to the conventional lymph node staging system in predicting outcome.
You have full text access to this OnlineOpen article
Radiotherapy or surgery for head and neck squamous cell cancer : Establishing the baseline for hypopharyngeal carcinoma? (pages 5711–5722)Stephen F. Hall, Patti A. Groome, Jonathan Irish and Brian O'Sullivan
Article first published online: 25 AUG 2009 | DOI: 10.1002/cncr.24635
The objective of this study was to compare the survival outcomes of the 2 traditional treatments for cancer of the hypopharynx. Contrary to the observational study literature, the authors found no survival advantage comparing primary surgery ± radiotherapy with primary radiotherapy with surgical salvage.
You have full text access to this OnlineOpen article
The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx (pages 5723–5733)Mark E. Zafereo, Matthew M. Hanasono, David I. Rosenthal, Erich M. Sturgis, Jan S. Lewin, Diana B. Roberts and Randal S. Weber
Article first published online: 16 SEP 2009 | DOI: 10.1002/cncr.24595
Age, disease-free interval, recurrent tumor stage, recurrent neck disease, and surgical margins influenced overall survival after surgical salvage in patients with recurrent squamous cell carcinoma of the oropharynx (SCCOP). Only a select group of patients with recurrent SCCOP were able to achieve long-term survival after salvage surgery, and favorable candidates were patients who were younger, had a disease-free interval after receiving definitive therapy, had small recurrent tumors for which negative surgical margins could be obtained, and had no recurrent neck disease.
Hematologic Malignancies
You have full text access to this OnlineOpen article
Primary plasma cell leukemia : A Surveillance, Epidemiology, and End Results database analysis between 1973 and 2004 (pages 5734–5739)Giridharan Ramsingh, Paul Mehan, Jingqin Luo, Ravi Vij and Daniel Morgensztern
Article first published online: 28 OCT 2009 | DOI: 10.1002/cncr.24700
This Surveillance, Epidemiology, and End Results database review of patients with plasma cell leukemia between 1973 and 2004 revealed that those with this disease had a dismal prognosis. Unlike survival with multiple myeloma, there was no evidence of improvement in the survival of patients with plasma cell leukemia over the decades that were studied.
You have full text access to this OnlineOpen article
Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera (pages 5740–5745)Naseema Gangat, Alexandra P. Wolanskyj, Susan M. Schwager, Curtis A. Hanson and Ayalew Tefferi
Article first published online: 5 OCT 2009 | DOI: 10.1002/cncr.24664
In this large study of 407 patients with low-risk essential thrombocythemia or polycythemia vera, leukocytosis at the time of diagnosis was not found to predict subsequent thrombotic complications. Advanced age was found to be significantly associated with arterial thrombosis in patients with polycythemia vera and a higher hemoglobin level with venous thrombosis in patients with essential thrombocythemia.
You have full text access to this OnlineOpen article
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities (pages 5746–5751)Farhad Ravandi, Jean-Pierre Issa, Guillermo Garcia-Manero, Susan O'Brien, Sherry Pierce, Jianqin Shan, Gautam Borthakur, Srdan Verstovsek, Stefan Faderl, Jorge Cortes and Hagop Kantarjian
Article first published online: 30 SEP 2009 | DOI: 10.1002/cncr.24661
The outcome of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with chromosome 5 and 7 abnormalities has been traditionally poor because of their inherent resistance to chemotherapy. Treatment with hypomethylating agents appears to be associated with a better overall survival, particularly for those patients with a lower presenting white cell count.
Melanoma
You have full text access to this OnlineOpen article
Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? (pages 5752–5760)Csaba Gajdos, Kent A. Griffith, Sandra L. Wong, Timothy M. Johnson, Alfred E. Chang, Vincent M. Cimmino, Lori Lowe, Carol R. Bradford, Riley S. Rees and Michael S. Sabel
Article first published online: 13 OCT 2009 | DOI: 10.1002/cncr.24660
Sentinel lymph node (SLN) biopsy for clinically lymph node-negative T4 melanoma is strongly indicated regardless of Breslow depth, as SLN status is the most significant prognostic sign among these patients. Nonulcerated T4 patients with a negative SLN have an excellent prognosis and should not be considered candidates for adjuvant high-dose interferon.
Neuro-Oncology
You have full text access to this OnlineOpen article
Outcome and prognostic features in pediatric gliomas : A review of 6212 cases from the Surveillance, Epidemiology, and End Results database (pages 5761–5770)Ibrahim Qaddoumi, Iyad Sultan and Amar Gajjar
Article first published online: 7 OCT 2009 | DOI: 10.1002/cncr.24663
In an analysis of 6212 patients younger than 20 years at diagnosis of glioma (1973-2005), tumor grade was the most significant independent prognostic factor except among patients younger than 1 year, in whom extent of resection was most significant. Despite its limitations, the Surveillance, Epidemiology, and End Results database provides a useful tool for studies of rare tumors such as pediatric gliomas.
You have full text access to this OnlineOpen article
Long-term surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors (pages 5771–5779)Ji Hoon Phi, Seung-Ki Kim, Byung-Kyu Cho, Seo Young Lee, Su Yeon Park, Sung-joon Park, Sang Kun Lee, Ki Joong Kim and Chun Kee Chung
Article first published online: 5 OCT 2009 | DOI: 10.1002/cncr.24666
In analyses of 87 patients with temporal lobe epilepsy associated with a low-grade brain tumor, the actuarial seizure and tumor control rates at the fifth year postoperatively were 79% and 90%, respectively. Complete resection of the tumor was important for both seizure and tumor control. For tumors confined to the amygdala or the parahippocampal gyrus, tailored resection focusing on the tumor resulted in a favorable outcome.
Discipline
Diagnostic Imaging
You have full text access to this OnlineOpen article
Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery (pages 5780–5787)Tulin Cil, Eve Fishell, Wedad Hanna, Ping Sun, Ellen Rawlinson, Steven A. Narod and David R. McCready
Article first published online: 9 NOV 2009 | DOI: 10.1002/cncr.24638
Mammographic breast density is an important risk factor for local breast cancer recurrence. Mammographic density should be taken into consideration when stratifying patients for clinical trials of partial breast radiotherapy. If confirmed, mammographic density might be used to help decide which patients might benefit from radiotherapy.
Disparities Research
You have full text access to this OnlineOpen article
Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women (pages 5788–5797)Swann A. Adams, Emily R. Smith, James Hardin, Irene Prabhu-Das, Jeanette Fulton and James R. Hebert
Article first published online: 26 OCT 2009 | DOI: 10.1002/cncr.24633
In a cohort of economically disadvantaged women, after accounting for the total time to the completion of procedures for the follow-up of abnormal mammography findings, African-American women were less likely than European-American women to complete the recommended procedures. These findings suggest the importance of developing interventions aimed at increasing the timeliness of recommended mammography follow-up among African-American women.
Epidemiology
You have full text access to this OnlineOpen article
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer (pages 5798–5806)Robert B. Hines, Chandrakumar Shanmugam, John W. Waterbor, Gerald McGwin Jr., Ellen Funkhouser, Christopher S. Coffey, James Posey and Upender Manne
Article first published online: 24 NOV 2009 | DOI: 10.1002/cncr.24598
Comorbidity and body mass index (BMI) were associated independently with mortality after surgery for colon cancer. However, neither comorbidity nor BMI could account for the increased risk of death among African Americans relative to Caucasians.
Medical Oncology
You have full text access to this OnlineOpen article
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy (pages 5807–5816)Wichit Arpornwirat, Istvan Albert, Vincent L. Hansen, Jeremey Levin, Rajesh R. Bandekar and Steven M. Grunberg
Article first published online: 15 OCT 2009 | DOI: 10.1002/cncr.24630
The addition of different dose regimens of the neurokinin-1 receptor antagonist casopitant to standard ondansetron/dexamethasone antiemetic prophylaxis increased the proportion of patients that achieved a complete response over the first 5 days after moderately emetogenic chemotherapy.
Pediatric Oncology
You have full text access to this OnlineOpen article
Impact of radiation and chemotherapy on risk of dental abnormalities : A report from the Childhood Cancer Survivor Study (pages 5817–5827)Sue C. Kaste, Pamela Goodman, Wendy Leisenring, Marilyn Stovall, Robert J. Hayashi, Mark Yeazel, Soraya Beiraghi, Melissa M. Hudson, Charles A. Sklar, Leslie L. Robison and K. Scott Baker
Article first published online: 15 OCT 2009 | DOI: 10.1002/cncr.24670
Controlling for chemotherapy and socioeconomic factors, radiation exposure of ≥20 Gray to dentition was associated significantly with an increased risk of >1 dental abnormality. Dose-dependent alkylating agent therapy significantly increased the risk of >1 anatomic/developmental dental abnormalities in survivors who were diagnosed at ages <5 years (odds ratios, 1.7, 2.7, and 3.3 for alkylating agent scores of 1, 2, and 3, respectively).
You have full text access to this OnlineOpen article
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma : A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group (pages 5828–5835)Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto Pappo, Wendy B. London and Marcio Malogolowkin
Article first published online: 7 OCT 2009 | DOI: 10.1002/cncr.24667
Amifostine in the doses and schedule used in Children's Oncology Group Study P9645 failed to significantly reduce the incidence of hearing loss and other platinum-induced toxicities in patients with hepatoblastoma.
Radiation Oncology
You have full text access to this OnlineOpen article
The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma (pages 5836–5844)Shefali Agrawal, John M. Kane III, Beverly A. Guadagnolo, William G. Kraybill and Matthew T. Ballo
Article first published online: 21 AUG 2009 | DOI: 10.1002/cncr.24627
Adjuvant radiation therapy was associated with improved regional lymph node basin control compared with therapeutic lymphadenectomy alone for patients who had high-risk, clinically advanced, lymph node-metastatic melanoma. The current results indicated that, although it is a regional therapy, adjuvant radiation therapy also may have an impact on disease-specific survival.